Literature DB >> 26391499

Screening asymptomatic patients with type 2 diabetes is recommended: Pro.

Mario Petretta1, Alberto Cuocolo2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26391499     DOI： 10.1007/s12350-015-0250-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  20 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

Authors:  Maryam Kavousi; Maarten J G Leening; David Nanchen; Philip Greenland; Ian M Graham; Ewout W Steyerberg; M Arfan Ikram; Bruno H Stricker; Albert Hofman; Oscar H Franco
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

3.  ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).

Authors:  Lars Rydén; Peter J Grant; Stefan D Anker; Christian Berne; Francesco Cosentino; Nicolas Danchin; Christi Deaton; Javier Escaned; Hans-Peter Hammes; Heikki Huikuri; Michel Marre; Nikolaus Marx; Linda Mellbin; Jan Ostergren; Carlo Patrono; Petar Seferovic; Miguel Sousa Uva; Marja-Riita Taskinen; Michal Tendera; Jaakko Tuomilehto; Paul Valensi; Jose Luis Zamorano; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Guy De Backer; Per Anton Sirnes; Eduardo Alegria Ezquerra; Angelo Avogaro; Lina Badimon; Elena Baranova; Helmut Baumgartner; John Betteridge; Antonio Ceriello; Robert Fagard; Christian Funck-Brentano; Dietrich C Gulba; David Hasdai; Arno W Hoes; John K Kjekshus; Juhani Knuuti; Philippe Kolh; Eli Lev; Christian Mueller; Ludwig Neyses; Peter M Nilsson; Joep Perk; Piotr Ponikowski; Zeljko Reiner; Naveed Sattar; Volker Schächinger; André Scheen; Henrik Schirmer; Anna Strömberg; Svetlana Sudzhaeva; Juan Luis Tamargo; Margus Viigimaa; Charalambos Vlachopoulos; Robert G Xuereb
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

4.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

5.  Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study.

Authors:  Frans J Th Wackers; Lawrence H Young
Journal:  J Nucl Cardiol       Date:  2009-08-15       Impact factor: 5.952

6.  Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study.

Authors:  O May; H Arildsen; E M Damsgaard; H Mickley
Journal:  Cardiovasc Res       Date:  1997-04       Impact factor: 10.787

7.  Screening asymptomatic diabetic patients for coronary artery disease: why not?

Authors:  Todd D Miller; Rita F Redberg; Frans J T Wackers
Journal:  J Am Coll Cardiol       Date:  2006-07-24       Impact factor: 24.094

8.  Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies.

Authors:  Lihua Zhang; Hong Li; Simin Zhang; Lindsay M Jaacks; Yufeng Li; Linong Ji
Journal:  J Diabetes Complications       Date:  2013-12-10       Impact factor: 2.852

9.  Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram.

Authors:  M Petretta; W Acampa; L Evangelista; S Daniele; E Zampella; R Assante; C Nappi; V Cantoni; G Fiumara; A Cuocolo
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-12-25       Impact factor: 4.222

10.  Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

Authors:  Michael J Zellweger; Michael Maraun; Hans H Osterhues; Ulrich Keller; Jan Müller-Brand; Raban Jeger; Otmar Pfister; Thilo Burkard; Friedrich Eckstein; Stefanie von Felten; Stefan Osswald; Matthias Pfisterer
Journal:  JACC Cardiovasc Imaging       Date:  2014-09-17
View more
  5 in total

Review 1.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  Comparison of ESC and ACC/AHA guidelines for myocardial revascularization: are the differences clinically relevant? The European perspective.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

3.  Screening asymptomatic patients with type 2 diabetes: The debates persist.

Authors:  George A Beller; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2015-09-21       Impact factor: 5.952

Review 4.  Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trials.

Authors:  Christophe Bauters; Gilles Lemesle
Journal:  BMC Cardiovasc Disord       Date:  2016-05-10       Impact factor: 2.298

Review 5.  Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.

Authors:  Konstantinos Makrilakis; Stavros Liatis
Journal:  J Diabetes Res       Date:  2017-12-14       Impact factor: 4.011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.